Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sodium-dependent phosphate transport protein type IIb (NaPi-IIb) is a membrane transporter that mediates the electrogenic cotransport of inorganic phosphate and sodium ions into cells, playing a central role in phosphate absorption, especially in the intestine and lung. The protein consists of 690 amino acids, with a molecular weight of approximately 75 kDa. It contains multiple transmembrane domains and is regulated by the parathyroid hormone and other factors. It is critical for systemic phosphate regulation, and its dysfunction leads to substantial disease phenotypes including pulmonary alveolar microlithiasis and altered bone formation. In cancer, NaPi-IIb serves as a tumor-associated antigen and is being pursued as a target for antibody-drug conjugate therapies in ovarian cancer.
Antibody-drug conjugate: Selective binding to NaPi-IIb on tumor cells delivers cytotoxic payload Inhibition or modulation of phosphate uptake via competitive or allosteric blockage (theoretical mechanism for small molecules, though clinical use is presently limited)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sodium-dependent phosphate transport protein type IIb (NaPi-IIb).